Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
Takeda Pharmaceutical Co.’s efforts to hide the cancer risks of its Actos diabetes medicine showed a “reckless disregard” for patient safety and a drive to protect billions of dollars in sales, a lawyer told jurors in the first federal trial over the medication.
Federal jurors began hearing a contract dispute today over whether Ingersoll Rand Plc owes $11 million or $72 million to 130 employees under an incentive plan tied to its sale of a subsidiary, Dresser-Rand Group Inc.
Takeda Pharmaceutical Co. executives hid the risks of its Actos diabetes drug from consumers and doctors and should be held liable for a former shopkeeper’s cancer, a lawyer said at the start of the first federal trial over the medication.
Takeda Pharmaceutical Co. must let a jury hear claims that it intentionally destroyed files related its Actos diabetes drug, a judge ruled before the first federal trial over allegations the pills cause bladder cancer.
Plaintiff lawyers involved in Merck & Co. ’s $4.85 billion Vioxx settlement are accusing some of their colleagues of attempting to hog the lion’s share of more than $315 million in fees spawned by the accord.